Industry News

ZIM to Launch ZIM eCommerce Baltimore eXpress (ZXB), a New Speedy eCommerce service from China and South-East Asia to the US East Coast

The New Service Expands ZIM's Speedy Premium Services for eCommerce Customers HAIFA, Israel, March 14, 2022 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd.  (NYSE: ZIM) announced today the launch of  ZIM Ecommerce Baltimore Express (ZXB), a new and speedy e-commerce ser...

2022-03-14 10:00 4097

Parpera & Railspay launch Australia's first embedded finance business debit card

SYDNEY, March 14, 2022 /PRNewswire/ -- Parpera , a money management platform for sole traders, freelancers, and startup founders, has launchedAustralia's first embedded finance business experience using a debit card linked directly to deposit accounts, in partnership wit...

2022-03-14 09:13 4368

Fasanara makes key hires as it looks to expand across products and geographies

LONDON, March 14, 2022 /PRNewswire/ -- Encouraged by the increasing interest in its suite of Fintech Investment Products, Fasanara Capital has made two significant additions to the team to strengthen deal origination and support the launch of its new Fintech-focused Venture Capital Fund. The fir...

2022-03-14 09:00 2624

Wolfoo - Vietnamese animation taking the world by storm

NEW YORK, March 11, 2022 /PRNewswire/ -- An animated web series popular with kids worldwide,Wolfoo enjoys wide appeal that stems from the humanistic values deftly woven into stories about fun everyday situations. The series has been twice awarded the Youtube Diamond button, with more than 2 billi...

2022-03-14 08:33 7871

InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Waldenström's Macroglobulinemia in China

BEIJING, March 13, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) accepted a supplemental New Drug Application (sNDA) for Bruton's tyros...

2022-03-14 08:30 2370

Giift, backed by Apis Growth Fund II, acquires a majority ownership in Xoxoday, a fintech disruptor in the rewards, incentives, and payout space

SINGAPORE, March 14, 2022 /PRNewswire/ -- Giift, a leading provider of loyalty management solutions around the globe, announced today that it has acquired a majority interest in Xoxoday, anIndia-based fintech disruptor in the rewards, incentives, and payout space. Giift's investment will enable X...

2022-03-14 08:18 5233

Gefen Releases a New Integrated BI Module

TEL AVIV, Israel, March 14, 2022 /PRNewswire/ -- Gefen (ASX: GFN) is announcing the release of a new BI (Business Intelligence) module for its software platform. The BI component generates custom reports that are based on aggregated data from across the gamut of ...

2022-03-14 08:14 2914

CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer

* GAVRETO is the first and only selective rearranged during transfection (RET) inhibitor approved inChina for the treatment of RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC) * The labeled indications of GAVRETO have been expanded after it was approved by...

2022-03-14 08:05 4551

Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as Heterologous Booster against Omicron Variant

TIANJIN, China, March 14, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that medRxiv, a preprint platform for preliminary biomedical research, published an academic paper1 on the efficacy of CanSinoBIO's Recombinant COVID-19 Vaccine ("Ad5-n...

2022-03-14 08:00 3754

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, announced today that...

2022-03-14 08:00 4979

Addibond™ obtains Solar Impulse Efficient Solution Label

BRUSSELS, March 14, 2022 /PRNewswire/ -- Solvay's water-soluble Addibond™ polymer , used as a thin layer to strengthen bonding between aluminum a...

2022-03-14 08:00 4302

CIMC helps HK battle pandemic by offering over 2,000 units of modular buildings

SHENZHEN, China, March 14, 2022 /PRNewswire/ -- CIMC Modular Building System will provide a total of 2,076 units of modular buildings to helpHong Kong fight against the COVID-19 pandemic. Modular transitional house being hoisted  

2022-03-14 07:27 4607

StashAway launches Accredited Investors access to private equity, venture capital, angel investing and digital assets

SINGAPORE, March 14, 2022 /PRNewswire/ -- StashAway has introduced an offering designed exclusively for Accredited Investors (AIs): StashAway Reserve. With StashAway Reserve, Accredited Investors can now access private equity and venture capital (PE and VC), angel investing deals, invest in digit...

2022-03-14 04:00 6758

Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacity to 530 Million Tablets Per Year

HANGZHOU, China and SHAOXING, China, March 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, HKEX: 1672) today announces that it has further expanded its ritonavir oral tablet production capacity to approximately 530 million tablets per year, to meet the potential escalation in the domesti...

2022-03-13 18:30 4713

Innovative new beauty technology "Cellester" makes V shaped face and beautiful bust possible. The secret to looking young forever revealed.

HONG KONG, March 12, 2022 /PRNewswire/ -- New beauty technology "Cellester " has recently launched, making younger looking face and more beautiful bust curves accessible to consumers inAsia. Cellester technology helps to awaken collagen production, rejuvenate the face an...

2022-03-12 10:15 4793

Crowdfunding Campaign of CR-Scan Lizard Coming to an End with Creality's Continuous Trend Leading

SHENZHEN, China, March 12, 2022 /PRNewswire/ -- In February, Creality launched the crowdfunding campaign for 3D scanner - CR-Scan Lizard on Kickstarter. The campaign made a stir among users with 1000 units in 17 minutes, and1 million dollars in 4 hours. Till now, Creality has received more than 2...

2022-03-12 03:32 6236

Lacework Ranked #6 on Forbes America's Best Startup Employers List

Forbes recognizes Lacework for accelerated growth and strong employee engagement as cloud security sector booms SAN JOSE, Calif., March 12, 2022 /PRNewswire/ -- Lacework, the data-driven security company for the cloud, today announced the company ranked sixth in Forbes' America's Best Startup Em...

2022-03-12 01:56 4553

Lakeshore Acquisition II Corp. Announces Closing of $69 Million Initial Public Offering

NEW YORK, March 11, 2022 /PRNewswire/ -- Lakeshore Acquisition II Corp. (the "Company"), a newly organized blank check company incorporated as aCayman Islands exempted company and led by Chairman and CEO Bill Chen, today announced the closing of its initial public offering of 6,900,000 units (whi...

2022-03-12 00:50 6447

Dot Inc. Announces the World's First Tactile Braille Display, Compatible with iPhone and iPad

* New Dot Pad display from Dot Inc. helps blind/low-vision users feel tactile images in real-time * It will be showcased at the CSUN's Assistive Technology Conference in March 2022 * Dot Pad is now available to developer communities and early adopters on Dot's official website SEOUL, South ...

2022-03-11 22:00 6068

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals ("Concert") to acquire a portfolio...

2022-03-11 21:38 8906